6 results
6-K
EX-99.1
SNY
Sanofi
28 Jul 23
Solid Q2 performance and strong pipeline momentum
3:35pm
)
Scope 1 & 2 GHG emissions reduction
Q1 2023
Q2 2023
GHG reduction vs 2019 %
Renewable electricity
Q1 2023
Q2 2023
% electricity consumption from
6-K
EX-99.2
SNY
Sanofi
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
our updated scope 3 reduction target of achieving -30% GHG emissions by 2030 vs our 2019 baseline.
Net Zero emissions means achieving a scale
6-K
EX-99.1
SNY
Sanofi
27 Apr 23
Strong Q1 growth driven by Specialty Care, Vaccines and CHC
11:39am
as well our updated scope 3 reduction target of achieving -30% GHG emissions by 2030 vs our 2019 baseline.
Net Zero emissions means achieving a scale … in progress
Eco-design digital solution launched
7 LCAs completed & 4 in progress (new products and marketed product)
Scope 1 & 2 GHG emissions reduction
6-K
EX-99.1
SNY
Sanofi
28 Oct 22
Continued strong growth in Q3 with key regulatory milestones achieved
11:16am
on how to reduce its emissions in the following areas: reducing GHG emissions from its activities, sourcing renewable energies, fostering an eco-fleet … , and working with suppliers and partners to reduce GHG emissions across its full value chain.
In parallel to our reduction efforts, Sanofi has
6-K
EX-99.2
SNY
Sanofi
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
– including on climate change – delivers important progress, we have upgraded our Scope 3 greenhouse gas (GHG) emissions reduction target from the initial 14
6-K
EX-99.1
paydg yigeggzn
28 Oct 21
Q3 2021 sales grew double digit to €10.4 billion (up 10.1%) due to strong growth from Dupixent®, Vaccines and CHC
11:19am
- Prev
- 1
- Next